Developer docs
API playgroundTry for free, no card

Search company profiles

Antares Vision

Full company profile

uuid0003yc1

Namestring
Antares Vision
Legal namestring
ANTARES VISION S.p.A.
Company typeenum
Private
Founded yearint
2007
Descriptiontext

Antares Vision S.p.A. is an Italian multinational, headquartered in Travagliato (Brescia), Italy, that designs and delivers systems for product quality inspection and end-to-end supply chain traceability. The company's core offering is the DIAMIND platform, an integrated ecosystem that combines hardware inspection machines and inline quality control systems with software-based track & trace, serialization, and cloud data management, running at the line, factory, warehouse, enterprise, and supply chain levels. Customers are primarily pharmaceutical and life sciences manufacturers, with secondary exposure to food & beverage, cosmetics, beverages, food, and rigid container producers, all operating under strict regulatory frameworks such as FDA requirements and the EU Falsified Medicines Directive.

The product portfolio centers on four pillars: Inspection Machines (standalone automated systems for parenteral products with CCIT technologies), Inspection Systems (inline controls for color, shape, size, integrity, pattern matching, and OCR-OCV), Track & Trace solutions (serialization and lifecycle monitoring for pharmaceutical compliance), and Supply Chain Transparency solutions (L1-L5 full-stack offerings combating counterfeits, diversion, and theft). The 2025 launch of AI-GO introduced artificial intelligence visual inspection as a differentiated product feature within the platform. The company monetizes through hardware sales of inspection equipment, recurring subscription software for track & trace and digital healthcare applications, and professional services for installation, validation, training, and ongoing support, distributed via a direct enterprise field sales motion with quote-based pricing.

Following Crane NXT's acquisition of an initial 32% stake in December 2025 (approximately EUR 117 million) and completion of the full takeover in April 2026, Antares Vision operates as a wholly owned subsidiary of Crane NXT within its Detection & Traceability Technologies segment, with an estimated enterprise value of approximately $3 billion. Prior to delisting from Euronext Milan, the company operated in over 60 countries and had expanded its digital supply chain footprint via the 2021 acquisition of Rfxcel.

Short descriptiontext

Antares Vision provides integrated hardware inspection systems and software-based track & trace solutions for pharmaceutical manufacturers and other regulated industries, unified under its DIAMIND platform, and now operates as a wholly owned subsidiary of Crane NXT following a 2026 acquisition.

Operating statusenum
Acquired
Ownership categoryenum
Headcount rangeband
1,001–5,000
akta.pro rankint
HeadquartersTravagliato, Italy
HQ citystring
Travagliato
HQ countrystring
Italy
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pharmaceutical inspection equipment, track and trace solutions, serialization compliance, supply chain transparency, visual inspection systems
Industry3 codes
1Snow & Ice Management (Plowing, Salting, De-icing)
CodeIMAIAIAFPrimaryYes
2Inspection, Checkweighing & Detection Systems (Vision, Metal, X-ray)
CodeIMALAOAHPrimaryNo
3Industrial Vision & Quality Inspection
CodeHDAAAEAGPrimaryNo
NAICS code3 codes
  • Instruments and Related Products Manufacturing for Measuring, Displaying, and Controlling Industrial Process Variables334513
  • Navigational, Measuring, Electromedical, and Control Instruments Manufacturing33451
  • Electronic and Precision Equipment Repair and Maintenance811210
SIC code2 codes
  • Industrial Instruments For Measurement, Display, And Control3823
  • Special Industry Machinery, Nec3559
Product category
Pharmaceutical Inspection Equipment
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model4 records
1Inspection Equipment & Systems
TypeHardware Sales
Description

Sale of hardware inspection machines, visual inspection systems, and inline quality control equipment for pharmaceutical and industrial applications. Equipment includes standalone automatic machines for parenteral products and integrated inspection solutions.

antaresvisiongroup.com
2Track & Trace Software & Solutions
TypeSubscription Recurring
Description

Software solutions for serialization, traceability, and supply chain transparency. Includes cloud-based data management and digital identity systems for products.

antaresvisiongroup.com
3Digital Healthcare Platform
TypeSubscription Recurring
Description

Medication management platform for digital healthcare applications, supporting pharmaceutical supply chain digitalization.

antaresvisiongroup.com
4Professional Services
TypeProfessional Services
Description

Services including installation, validation, training, and ongoing support for inspection and traceability systems.

antaresvisiongroup.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Supply Chain, Operations, Marketing or Sales
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 4 records shown
1DIAMIND
Description

Integrated, intelligent ecosystem of solutions to power products and supply chains, enabling a data-driven and tailored journey to digital innovation. Connects physical products with digital identities and runs at line, factory, warehouse, enterprise, and supply chain levels.

antaresvisiongroup.com
+3 more records
Core offering1 text field

Antares Vision develops and manufactures hardware inspection machines and software solutions for product quality inspection, serialization, and end-to-end supply chain traceability. Its DIAMIND ecosystem combines inline visual inspection systems, standalone inspection machines, and cloud-based track & trace platforms to help pharmaceutical, food & beverage, cosmetics, and other regulated manufacturers comply with global serialization mandates and protect against counterfeiting.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Antares Vision Group offers a unified product portfolio organized around the DIAMIND ecosystem, an integrated intelligent platform connecting physical products with digital identities across line, factory, warehouse, enterprise, and supply chain levels. The core product suite includes Track & Trace solutions for pharmaceutical regulatory compliance, Inspection Machines (standalone automated systems for parenteral products with visual inspection and CCIT technologies), Inspection Systems (inline quality controls for production lines), and Supply Chain Transparency solutions (L1-L5 full-stack serialization and traceability). The portfolio is enhanced by AI-GO, an artificial intelligence visual inspection system, and a Medication Management Platform for digital healthcare applications.

Product and service6 records
1Track & Trace
CategorySerialization and traceability
Description

Comprehensive hardware and software solutions enabling pharmaceutical manufacturers to comply with global regulatory requirements, protect patients, and ensure supply chain reliability by tracking and monitoring products throughout their entire lifecycle.

2Inspection Machines
CategoryInspection equipment
Description

Standalone automatic machines dedicated to parenteral products featuring advanced visual inspection solutions and multiple Container Closure Integrity Testing (CCIT) technologies, designed to guarantee product quality, integrity, and safety while meeting regulatory requirements.

3Inspection Systems
CategoryInspection equipment
Description

Inline, integrated visual inspection systems providing quality controls for pharmaceutical products and medical devices on production lines, including color, shape, size, integrity, mixing-up, pattern matching, OCR-OCV, and code reading inspections.

4Supply Chain Transparency
CategorySupply chain management software
Description

End-to-end digital supply chain visibility solutions providing validated, preconfigured systems supporting serialization and traceability requirements, global reporting access, and combating counterfeits, diversion, and theft with full-stack L1-L5 solutions.

5Medication Management Platform
CategoryDigital healthcare
Description

Digital healthcare platform for medication management enabling healthcare providers to manage and track medication administration, inventory, and patient safety.

6AI-GO
CategoryAI visual inspection
Description

Artificial intelligence solution revolutionizing visual inspection controls in pharmaceutical manufacturing, enabling automated quality inspection with advanced defect detection capabilities for color, shape, size, integrity, mixing-up, pattern matching, and code reading.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
1Systech (Dover)
TypeDirect peer
Description

Systech provides serialization, authentication, and supply chain traceability solutions for pharmaceuticals and consumer goods, competing with Antares Vision's serialization and brand protection offerings within the DIAMIND ecosystem.

TypeDirect peer
Description

Syntegon is a major supplier of inspection and packaging machinery for the pharmaceutical and food industries, offering visual inspection, serialization, and track & trace systems that directly overlap with Antares Vision's inspection machines, CCIT, and track & trace portfolio.

TypeDirect peer
Description

Cognex is a global leader in machine vision systems and industrial barcode readers used for quality inspection and traceability across pharmaceutical, food & beverage, and consumer goods manufacturing, directly competing with Antares Vision's inspection systems and AI-GO offerings.

TypeDirect peer
Description

TraceLink is a leading pharmaceutical serialization and supply chain traceability network, competing with Antares Vision's Track & Trace and Supply Chain Transparency offerings for global pharma manufacturers managing DSCSA, EU FMD, and other compliance mandates.

TypeDirect peer
Description

Keyence provides industrial sensors, machine vision systems, and code readers for inline quality inspection and traceability, overlapping with Antares Vision's inspection machines and inline quality controls for pharmaceutical and consumer product manufacturers.

TypeBroad incumbent
Description

Siemens offers industrial automation, machine vision, and digital factory solutions through SIMATIC and TIA Portal ecosystems, serving the same pharma and food & beverage customers as Antares Vision with a much broader portfolio including controllers, drives, and MES software.

TypeDirect peer
Description

Optel provides serialization, track & trace, and supply chain visibility solutions for pharmaceuticals and food & beverage, with L1-L5 capabilities comparable to Antares Vision's DIAMIND platform and a similar focus on regulatory compliance globally.

TypeBroad incumbent
Description

Rockwell Automation delivers industrial control, vision, and analytics solutions including the Plex and FactoryTalk platforms, serving pharmaceutical and consumer goods manufacturers that overlap with Antares Vision's regulated-industry customer base.

TypeBroad incumbent
Description

Honeywell offers process automation, sensors, and digital transformation solutions for life sciences and food processing manufacturers, providing competing vision and inspection capabilities within a much broader industrial software and controls portfolio.

TypeDirect peer
Description

Körber Pharma offers inspection, serialization, and packaging solutions for pharmaceutical manufacturers, directly competing with Antares Vision's inspection systems and track & trace product lines in regulated life sciences markets.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment6 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability2 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors2 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment2 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Antares Vision

Pharmaceutical Inspection Equipmentantaresvision.com

Antares Vision provides integrated hardware inspection systems and software-based track & trace solutions for pharmaceutical manufacturers and other regulated industries, unified under its DIAMIND platform, and now operates as a wholly owned subsidiary of Crane NXT following a 2026 acquisition.

What Antares Vision does

Antares Vision S.p.A. is an Italian multinational, headquartered in Travagliato (Brescia), Italy, that designs and delivers systems for product quality inspection and end-to-end supply chain traceability. The company's core offering is the DIAMIND platform, an integrated ecosystem that combines hardware inspection machines and inline quality control systems with software-based track & trace, serialization, and cloud data management, running at the line, factory, warehouse, enterprise, and supply chain levels. Customers are primarily pharmaceutical and life sciences manufacturers, with secondary exposure to food & beverage, cosmetics, beverages, food, and rigid container producers, all operating under strict regulatory frameworks such as FDA requirements and the EU Falsified Medicines Directive.

The product portfolio centers on four pillars: Inspection Machines (standalone automated systems for parenteral products with CCIT technologies), Inspection Systems (inline controls for color, shape, size, integrity, pattern matching, and OCR-OCV), Track & Trace solutions (serialization and lifecycle monitoring for pharmaceutical compliance), and Supply Chain Transparency solutions (L1-L5 full-stack offerings combating counterfeits, diversion, and theft). The 2025 launch of AI-GO introduced artificial intelligence visual inspection as a differentiated product feature within the platform. The company monetizes through hardware sales of inspection equipment, recurring subscription software for track & trace and digital healthcare applications, and professional services for installation, validation, training, and ongoing support, distributed via a direct enterprise field sales motion with quote-based pricing.

Following Crane NXT's acquisition of an initial 32% stake in December 2025 (approximately EUR 117 million) and completion of the full takeover in April 2026, Antares Vision operates as a wholly owned subsidiary of Crane NXT within its Detection & Traceability Technologies segment, with an estimated enterprise value of approximately $3 billion. Prior to delisting from Euronext Milan, the company operated in over 60 countries and had expanded its digital supply chain footprint via the 2021 acquisition of Rfxcel.

Antares Vision firmographics

Firmographics
Name
Antares Vision
Legal name
ANTARES VISION S.p.A.
Website
https://antaresvision.com
Company type
Private
Founded year
2007
Operating status
Acquired
Headcount range
1,001–5,000 employees
Short description
Antares Vision provides integrated hardware inspection systems and software-based track & trace solutions for pharmaceutical manufacturers and other regulated industries, unified under its DIAMIND platform, and now operates as a wholly owned subsidiary of Crane NXT following a 2026 acquisition.
Ownership category
akta.pro rank

Antares Vision industry classification

Industry
Product category
Pharmaceutical Inspection Equipment
NAICS
Instruments and Related Products Manufacturing for Measuring, Displaying, and Controlling Industrial Process Variables (334513), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451), Electronic and Precision Equipment Repair and Maintenance (811210)
SIC
Industrial Instruments For Measurement, Display, And Control (3823), Special Industry Machinery, Nec (3559)
akta.pro primary industry
Snow & Ice Management (Plowing, Salting, De-icing) (IMAIAIAF)
akta.pro secondary industries
Inspection, Checkweighing & Detection Systems (Vision, Metal, X-ray) (IMALAOAH), Industrial Vision & Quality Inspection (HDAAAEAG)

Keywords

  • Pharmaceutical inspection equipment
  • Track and trace solutions
  • Serialization compliance
  • Supply chain transparency
  • Visual inspection systems

Where Antares Vision is headquartered

Location

Headquarters

HQ city
Travagliato
HQ country
Italy
HQ region
Europe

Offices1 record

Markets served

Antares Vision business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Technology or R&D, Supply Chain, Operations, Marketing or Sales

Revenue model

  1. Inspection Equipment & Systems: Sale of hardware inspection machines, visual inspection systems, and inline quality control equipment for pharmaceutical and industrial applications. Equipment includes standalone automatic machines for parenteral products and integrated inspection solutions.
  2. Track & Trace Software & Solutions: Software solutions for serialization, traceability, and supply chain transparency. Includes cloud-based data management and digital identity systems for products.
  3. Digital Healthcare Platform: Medication management platform for digital healthcare applications, supporting pharmaceutical supply chain digitalization.
  4. Professional Services: Services including installation, validation, training, and ongoing support for inspection and traceability systems.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Antares Vision product offering

Product offering

Core offering

Antares Vision develops and manufactures hardware inspection machines and software solutions for product quality inspection, serialization, and end-to-end supply chain traceability. Its DIAMIND ecosystem combines inline visual inspection systems, standalone inspection machines, and cloud-based track & trace platforms to help pharmaceutical, food & beverage, cosmetics, and other regulated manufacturers comply with global serialization mandates and protect against counterfeiting.

Product overview

Antares Vision Group offers a unified product portfolio organized around the DIAMIND ecosystem, an integrated intelligent platform connecting physical products with digital identities across line, factory, warehouse, enterprise, and supply chain levels. The core product suite includes Track & Trace solutions for pharmaceutical regulatory compliance, Inspection Machines (standalone automated systems for parenteral products with visual inspection and CCIT technologies), Inspection Systems (inline quality controls for production lines), and Supply Chain Transparency solutions (L1-L5 full-stack serialization and traceability). The portfolio is enhanced by AI-GO, an artificial intelligence visual inspection system, and a Medication Management Platform for digital healthcare applications.

Differentiator

Problem solved

Functional benefit

Brands

  • DIAMIND: Integrated, intelligent ecosystem of solutions to power products and supply chains, enabling a data-driven and tailored journey to digital innovation. Connects physical products with digital identities and runs at line, factory, warehouse, enterprise, and supply chain levels.
  • AI-GO
  • Digital Factory
  • Inspecta

Products and services

  • Track & Trace Comprehensive hardware and software solutions enabling pharmaceutical manufacturers to comply with global regulatory requirements, protect patients, and ensure supply chain reliability by tracking and monitoring products throughout their entire lifecycle.
  • Inspection Machines Standalone automatic machines dedicated to parenteral products featuring advanced visual inspection solutions and multiple Container Closure Integrity Testing (CCIT) technologies, designed to guarantee product quality, integrity, and safety while meeting regulatory requirements.
  • Inspection Systems Inline, integrated visual inspection systems providing quality controls for pharmaceutical products and medical devices on production lines, including color, shape, size, integrity, mixing-up, pattern matching, OCR-OCV, and code reading inspections.
  • Supply Chain Transparency End-to-end digital supply chain visibility solutions providing validated, preconfigured systems supporting serialization and traceability requirements, global reporting access, and combating counterfeits, diversion, and theft with full-stack L1-L5 solutions.
  • Medication Management Platform Digital healthcare platform for medication management enabling healthcare providers to manage and track medication administration, inventory, and patient safety.
  • AI-GO Artificial intelligence solution revolutionizing visual inspection controls in pharmaceutical manufacturing, enabling automated quality inspection with advanced defect detection capabilities for color, shape, size, integrity, mixing-up, pattern matching, and code reading.

Companies that use Antares Vision

Customer profile

Segments6 records

Ideal customer profiles2 records

Antares Vision technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature6 records

Antares Vision partnerships and signals

Strategic signal

Scale indicators3 records

Recent moves7 records

Expansion highlights5 records

Antares Vision competitors and assessment

Company assessment

Direct peers

  • Systech (Dover): Systech provides serialization, authentication, and supply chain traceability solutions for pharmaceuticals and consumer goods, competing with Antares Vision's serialization and brand protection offerings within the DIAMIND ecosystem.
  • Syntegon Technology (formerly Bosch Packaging Technology): Syntegon is a major supplier of inspection and packaging machinery for the pharmaceutical and food industries, offering visual inspection, serialization, and track & trace systems that directly overlap with Antares Vision's inspection machines, CCIT, and track & trace portfolio.
  • Cognex Corporation: Cognex is a global leader in machine vision systems and industrial barcode readers used for quality inspection and traceability across pharmaceutical, food & beverage, and consumer goods manufacturing, directly competing with Antares Vision's inspection systems and AI-GO offerings.
  • TraceLink: TraceLink is a leading pharmaceutical serialization and supply chain traceability network, competing with Antares Vision's Track & Trace and Supply Chain Transparency offerings for global pharma manufacturers managing DSCSA, EU FMD, and other compliance mandates.
  • Keyence Corporation: Keyence provides industrial sensors, machine vision systems, and code readers for inline quality inspection and traceability, overlapping with Antares Vision's inspection machines and inline quality controls for pharmaceutical and consumer product manufacturers.
  • Optel Group: Optel provides serialization, track & trace, and supply chain visibility solutions for pharmaceuticals and food & beverage, with L1-L5 capabilities comparable to Antares Vision's DIAMIND platform and a similar focus on regulatory compliance globally.
  • Körber Pharma: Körber Pharma offers inspection, serialization, and packaging solutions for pharmaceutical manufacturers, directly competing with Antares Vision's inspection systems and track & trace product lines in regulated life sciences markets.

Broad incumbents

  • Siemens Digital Industries: Siemens offers industrial automation, machine vision, and digital factory solutions through SIMATIC and TIA Portal ecosystems, serving the same pharma and food & beverage customers as Antares Vision with a much broader portfolio including controllers, drives, and MES software.
  • Rockwell Automation: Rockwell Automation delivers industrial control, vision, and analytics solutions including the Plex and FactoryTalk platforms, serving pharmaceutical and consumer goods manufacturers that overlap with Antares Vision's regulated-industry customer base.
  • Honeywell Process Solutions: Honeywell offers process automation, sensors, and digital transformation solutions for life sciences and food processing manufacturers, providing competing vision and inspection capabilities within a much broader industrial software and controls portfolio.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Antares Vision social profiles

Digital presence

Antares Vision financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Antares Vision leadership team

Management profile

Number of profiles

Profiles4 records

Antares Vision funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Antares Vision M&A and investment

M&A and investment

M&A1 record

Investments2 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Antares Vision

What does Antares Vision do?

Antares Vision develops and manufactures hardware inspection machines and software solutions for product quality inspection, serialization, and end-to-end supply chain traceability. Its DIAMIND ecosystem combines inline visual inspection systems, standalone inspection machines, and cloud-based track & trace platforms to help pharmaceutical, food & beverage, cosmetics, and other regulated manufacturers comply with global serialization mandates and protect against counterfeiting.

Is Antares Vision a public or private company?

Antares Vision is a private company. It is classified as corporate owned and is currently acquired.

When was Antares Vision founded?

Antares Vision was founded in 2007. It employs 1,001 to 5,000 people.

Where is Antares Vision based?

Antares Vision is headquartered in Travagliato, Italy, in the Europe region.

How does Antares Vision make money?

Four revenue lines are on record. Inspection Equipment & Systems are the primary driver. The others are track & Trace Software & Solutions, digital Healthcare Platform and professional Services.

Who are Antares Vision's main competitors?

Direct peers on record are Systech (Dover), Syntegon Technology (formerly Bosch Packaging Technology), Cognex Corporation, TraceLink, Keyence Corporation, Optel Group and Körber Pharma. Broad incumbents are Siemens Digital Industries, Rockwell Automation and Honeywell Process Solutions.

Does Antares Vision have an API?

No public API is recorded for Antares Vision.

What industry is Antares Vision in?

Antares Vision's product category is Pharmaceutical Inspection Equipment. Its primary akta.pro industry code is IMAIAIAF, Snow & Ice Management (Plowing, Salting, De-icing), with a secondary code of IMALAOAH, Inspection, Checkweighing & Detection Systems (Vision, Metal, X-ray). Its NAICS code is 334513 and its SIC code is 3823.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
GlobeNewswireCrane NXT Reports Second Quarter 2026 ResultsCrane NXT reported Q2 2026 sales of $493 million, up 22% year-over-year, with adjusted EPS of $1.10. The company raised its full-year adjusted EPS guidance to $4.22–$4.42 from $4.10–$4.40. It also announced a Q3 dividend of $0.18 per share.PR NewswireEND-TO-END INNOVATION FOR THE SUPPLY CHAIN: ANTARES VISION GROUP TAKES CENTER STAGE AT EXPO PACK 2026Antares Vision Group will showcase inspection, traceability, and authentication solutions at Expo Pack Santa Fe 2026 in Mexico from June 2-5. The company highlights an ALL-IN-ONE system combining visual inspection, contaminant detection, and weight verification, plus serialization for end-to-end traceability. The group aims to help food and beverage companies improve efficiency, quality control, and product safety.GlobeNewswireCrane NXT Reports First Quarter 2026 ResultsCrane NXT reported Q1 2026 net sales of $388 million, up 17% year-over-year, with organic growth of 6%. Adjusted EPS was $0.60, and the company updated its full-year sales guidance to 15-17% growth. It also completed the acquisition of Antares Vision for approximately €362 million.citybizCrane NXT Acquires Antares VisionCrane NXT, Co. has successfully completed the acquisition of Antares Vision S.p.A., delisting the company from the Euronext Milan stock exchange and making it a wholly owned subsidiary. The acquisition expands Crane NXT's capabilities in authentication and traceability technologies and positions the company to capture growth opportunities in the life sciences and food & beverage markets. Antares Vision will be consolidated into Crane NXT's newly established Detection & Traceability Technologies segment, with updated 2026 guidance to be provided in the Q1 2026 earnings release.GlobeNewswireCrane NXT Completes Acquisition of Antares VisionCrane NXT, Co. has completed its acquisition of Antares Vision S.p.A., with the Italian company now delisted from Euronext Milan and operating as a wholly owned subsidiary. The acquisition adds market-leading capabilities in detection, inspection, and traceability technologies while expanding Crane NXT into the approximately $3 billion life sciences and food & beverage sectors. Antares Vision will be integrated into Crane NXT's newly established Detection & Traceability Technologies segment, with consolidated financial results and updated 2026 guidance to follow.Global BankingItaly revises enhanced voting rights rules in listed firmsItaly's government has drafted a decree to freeze enhanced voting rights at shareholder meetings voting on delisting or relocation abroad, aiming to prevent controlling shareholders from exploiting the mechanism to force minority investors out of listed companies. The reform also lifts a ban on interlocking directorates in the banking and insurance sector, with the government arguing that stricter 'fit and proper' manager assessments will achieve similar safeguards. The changes respond to investor complaints, notably in the takeover of Antares Vision by U.S. group Crane NXT, while Italy's equity market capitalization stands at just 48% of GDP, among the lowest in advanced economies.Investing.comCrane NXT completes first phase of Antares Vision acquisition By Investing.comCrane NXT, Co. completed the first phase of its acquisition of Antares Vision S.p.A., purchasing approximately 32% of the Italian company for €117 million (€5.00 per share) from Regolo S.p.A. and Sargas S.r.L. following receipt of all required regulatory approvals. The industrial technology company plans to launch a mandatory tender offer for the remaining publicly traded shares at the same price, with delisting of Antares Vision expected to be completed in 2026. Antares Vision specializes in quality control, traceability, and integrated data management technologies for the Life Sciences and Food & Beverage sectors, employing approximately 1,200 people and operating in more than 60 countries.Investing.comCrane NXT completes first phase of Antares Vision acquisition By Investing.comCrane NXT has completed the first phase of its acquisition of Antares Vision, purchasing approximately 32% of the Italian company for €117 million. This initial stake was acquired from Regolo S.p.A. and Sargas S.r.L following regulatory approval, with a mandatory tender offer for remaining shares planned next. The transaction aims to expand Crane NXT's portfolio into the Life Sciences and Food & Beverage sectors, with full delisting expected by 2026.Express PharmaCrane NXT to acquire Antares Vision; overall transaction expected to close in first half of 2026Crane NXT announced the acquisition of a significant stake in Antares Vision with the intent to take the company private, expanding its portfolio in the life sciences and food & beverage sectors. The transaction involves an initial purchase of approximately 30% for €120 million, followed by a mandatory tender offer for remaining shares at €5.00 per share, resulting in a total enterprise value of approximately €445 million. The deal is expected to close in the first half of 2026, subject to regulatory approvals.StockStoryCXT Q3 Deep Dive: Currency Momentum, Vending Weakness, and Strategic Portfolio ExpansionCrane NXT reported Q3 CY2025 revenue of $445.1 million and non-GAAP EPS of $1.28, both beating analyst estimates, driven by strong international currency demand and successful integration of De La Rue's authentication business. Despite the earnings beat, management lowered its full-year adjusted EPS guidance to $4.05 due to persistent weakness in the vending segment caused by tariff-related price increases and customer delays. The company is simultaneously pursuing strategic growth through the planned acquisition of Antares Vision to diversify into life sciences and food & beverage markets.